July 12, 2026

Suro Senen

Bridging the Gap: The Advancing Women’s Health Coverage Act Seeks to Modernize Post-Mastectomy Care bridging-the-gap-the-advancing-womens-health-coverage-act-seeks-to-modernize-post-mastectomy-care

Bridging the Gap: The Advancing Women’s Health Coverage Act Seeks to Modernize Post-Mastectomy Care

Suro Senen July 9, 2026
ARLINGTON HEIGHTS, IL — For millions of women across the United States, a breast cancer diagnosis is...
Read More Read more about Bridging the Gap: The Advancing Women’s Health Coverage Act Seeks to Modernize Post-Mastectomy Care
Precision in the Operating Room: AI Breakthrough Promises Safer Outcomes for Large-Volume Liposuction precision-in-the-operating-room-ai-breakthrough-promises-safer-outcomes-for-large-volume-liposuction

Precision in the Operating Room: AI Breakthrough Promises Safer Outcomes for Large-Volume Liposuction

Suro Senen July 8, 2026
A groundbreaking development in the field of cosmetic surgery is set to redefine patient safety protocols for...
Read More Read more about Precision in the Operating Room: AI Breakthrough Promises Safer Outcomes for Large-Volume Liposuction
Mount Sinai Scientists Unveil "Trojan Horse" Immunotherapy That Targets Cancer’s Protectors, Not Just the Cancer Itself mount-sinai-scientists-unveil-trojan-horse-immunotherapy-that-targets-cancers-protectors-not-just-the-cancer-itself

Mount Sinai Scientists Unveil "Trojan Horse" Immunotherapy That Targets Cancer’s Protectors, Not Just the Cancer Itself

Suro Senen July 5, 2026
NEW YORK, NY – January 22, 2024 – In a significant paradigm shift for cancer treatment, scientists...
Read More Read more about Mount Sinai Scientists Unveil "Trojan Horse" Immunotherapy That Targets Cancer’s Protectors, Not Just the Cancer Itself
Breakthrough in Precision Oncology: FDA Approves Trodelvy for Metastatic Triple-Negative Breast Cancer breakthrough-in-precision-oncology-fda-approves-trodelvy-for-metastatic-triple-negative-breast-cancer

Breakthrough in Precision Oncology: FDA Approves Trodelvy for Metastatic Triple-Negative Breast Cancer

Suro Senen July 4, 2026
The landscape of breast cancer treatment has undergone a seismic shift following the recent announcement from the...
Read More Read more about Breakthrough in Precision Oncology: FDA Approves Trodelvy for Metastatic Triple-Negative Breast Cancer
Bridging the Coverage Gap: The Advancing Women’s Health Coverage Act Seeks to Modernize Post-Mastectomy Care bridging-the-coverage-gap-the-advancing-womens-health-coverage-act-seeks-to-modernize-post-mastectomy-care

Bridging the Coverage Gap: The Advancing Women’s Health Coverage Act Seeks to Modernize Post-Mastectomy Care

Suro Senen July 1, 2026
ARLINGTON HEIGHTS, IL — For millions of women across the United States, a breast cancer diagnosis is...
Read More Read more about Bridging the Coverage Gap: The Advancing Women’s Health Coverage Act Seeks to Modernize Post-Mastectomy Care

You may have missed

the-frontlines-of-mbc-advocacy-metavivor-navigates-fiscal-uncertainty-and-legislative-hurdles-in-march-update

The Frontlines of MBC Advocacy: METAvivor Navigates Fiscal Uncertainty and Legislative Hurdles in March Update

Neng Nana July 12, 2026
navigating-the-frontiers-of-progress-a-presidential-update-on-research-and-advocacy

Navigating the Frontiers of Progress: A Presidential Update on Research and Advocacy

Dwi Wanna July 12, 2026
beyond-weight-loss-how-retatrutide-is-redefining-metabolic-medicine-and-cementing-lillys-market-dominance

Beyond Weight Loss: How Retatrutide is Redefining Metabolic Medicine and Cementing Lilly’s Market Dominance

Ammar Sabilarrohman July 12, 2026
global-health-at-a-crossroads-outcomes-of-the-79th-world-health-assembly-1

Global Health at a Crossroads: Outcomes of the 79th World Health Assembly

Nana July 12, 2026